Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil for Glycemic Control in Type 2 Diabetes
NCT04507438Phase 2Terminated
- Sponsor
- University of Maryland, Baltimore
- Start
- Jul 2019
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of donepezil in type 2 diabetes mellitus (T2DM), sponsored by University of Maryland, Baltimore. Started Jul 2019; status: terminated.
02
Drugs
donepezil
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04507438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04507438.